 | • レポートコード：B-GIR09D4272 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール • 産業分類：医薬品・ヘルスケア |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、ルフィナミドの世界市場について調べ、まとめました。種類別セグメントは、タブレット、経口懸濁液等、用途別セグメントは、成人、小児患者等に区分しました。ルフィナミドの世界市場概観、企業動向、企業別ルフィナミドシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・ルフィナミドの市場概観 ・ルフィナミドの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・ルフィナミドの企業別販売動向、市場シェア、市場集中度、競争動向 ・ルフィナミドの世界市場規模 ・ルフィナミドの北米市場分析（アメリカ、カナダ、メキシコ等） ・ルフィナミドのアメリカ市場規模推移 ・ルフィナミドのカナダ市場規模推移 ・ルフィナミドのメキシコ市場規模推移 ・ルフィナミドのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・ルフィナミドのドイツ市場規模推移 ・ルフィナミドのイギリス市場規模推移 ・ルフィナミドのロシア市場規模推移 ・ルフィナミドのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・ルフィナミドの日本市場規模推移 ・ルフィナミドの中国市場規模推移 ・ルフィナミドの韓国市場規模推移 ・ルフィナミドのインド市場規模推移 ・ルフィナミドの東南アジア市場規模推移 ・ルフィナミドの南米市場分析（ブラジル、アルゼンチン等） ・ルフィナミドの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・ルフィナミドの種類別分析/販売量、売上、市場シェア（タブレット、経口懸濁液） ・ルフィナミドの用途別分析/市場規模（成人、小児患者） ・ルフィナミドの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・ルフィナミドの販売チャネル・代理店・貿易業者・ディーラー分析 |
Rufinamide is an anticonvulsant medication. It is used in combination with other medication and therapy to treat Lennox–Gastaut syndrome and various other seizure disorders.
Scope of the Report:
The global Rufinamide market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Rufinamide.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Rufinamide market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Rufinamide market by product type and applications/end industries.
Market Segment by Companies, this report covers
Eisai
Glenmark Pharms
Mylan
West-ward Pharms
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Oral suspension
Market Segment by Applications, can be divided into
Adults
Pediatric patients
Table of Contents
1 Rufinamide Market Overview
1.1 Product Overview and Scope of Rufinamide
1.2 Classification of Rufinamide by Types
1.2.1 Global Rufinamide Revenue Comparison by Types (2019-2024)
1.2.2 Global Rufinamide Revenue Market Share by Types in 2018
1.2.3 Tablets
1.2.4 Oral suspension
1.3 Global Rufinamide Market by Application
1.3.1 Global Rufinamide Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Adults
1.3.3 Pediatric patients
1.4 Global Rufinamide Market by Regions
1.4.1 Global Rufinamide Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Rufinamide Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Rufinamide Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Rufinamide Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Rufinamide Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Rufinamide Status and Prospect (2014-2024)
1.5 Global Market Size of Rufinamide (2014-2024)
2 Manufacturers Profiles
2.1 Eisai
2.1.1 Business Overview
2.1.2 Rufinamide Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Eisai Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
2.2 Glenmark Pharms
2.2.1 Business Overview
2.2.2 Rufinamide Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
2.3 Mylan
2.3.1 Business Overview
2.3.2 Rufinamide Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Mylan Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
2.4 West-ward Pharms
2.4.1 Business Overview
2.4.2 Rufinamide Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
3 Global Rufinamide Market Competition, by Players
3.1 Global Rufinamide Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Rufinamide Players Market Share
3.2.2 Top 10 Rufinamide Players Market Share
3.3 Market Competition Trend
4 Global Rufinamide Market Size by Regions
4.1 Global Rufinamide Revenue and Market Share by Regions
4.2 North America Rufinamide Revenue and Growth Rate (2014-2019)
4.3 Europe Rufinamide Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Rufinamide Revenue and Growth Rate (2014-2019)
4.5 South America Rufinamide Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Rufinamide Revenue and Growth Rate (2014-2019)
5 North America Rufinamide Revenue by Countries
5.1 North America Rufinamide Revenue by Countries (2014-2019)
5.2 USA Rufinamide Revenue and Growth Rate (2014-2019)
5.3 Canada Rufinamide Revenue and Growth Rate (2014-2019)
5.4 Mexico Rufinamide Revenue and Growth Rate (2014-2019)
6 Europe Rufinamide Revenue by Countries
6.1 Europe Rufinamide Revenue by Countries (2014-2019)
6.2 Germany Rufinamide Revenue and Growth Rate (2014-2019)
6.3 UK Rufinamide Revenue and Growth Rate (2014-2019)
6.4 France Rufinamide Revenue and Growth Rate (2014-2019)
6.5 Russia Rufinamide Revenue and Growth Rate (2014-2019)
6.6 Italy Rufinamide Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Rufinamide Revenue by Countries
7.1 Asia-Pacific Rufinamide Revenue by Countries (2014-2019)
7.2 China Rufinamide Revenue and Growth Rate (2014-2019)
7.3 Japan Rufinamide Revenue and Growth Rate (2014-2019)
7.4 Korea Rufinamide Revenue and Growth Rate (2014-2019)
7.5 India Rufinamide Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Rufinamide Revenue and Growth Rate (2014-2019)
8 South America Rufinamide Revenue by Countries
8.1 South America Rufinamide Revenue by Countries (2014-2019)
8.2 Brazil Rufinamide Revenue and Growth Rate (2014-2019)
8.3 Argentina Rufinamide Revenue and Growth Rate (2014-2019)
8.4 Colombia Rufinamide Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Rufinamide by Countries
9.1 Middle East and Africa Rufinamide Revenue by Countries (2014-2019)
9.2 Saudi Arabia Rufinamide Revenue and Growth Rate (2014-2019)
9.3 UAE Rufinamide Revenue and Growth Rate (2014-2019)
9.4 Egypt Rufinamide Revenue and Growth Rate (2014-2019)
9.5 Nigeria Rufinamide Revenue and Growth Rate (2014-2019)
9.6 South Africa Rufinamide Revenue and Growth Rate (2014-2019)
10 Global Rufinamide Market Segment by Type
10.1 Global Rufinamide Revenue and Market Share by Type (2014-2019)
10.2 Global Rufinamide Market Forecast by Type (2019-2024)
10.3 Tablets Revenue Growth Rate (2014-2024)
10.4 Oral suspension Revenue Growth Rate (2014-2024)
11 Global Rufinamide Market Segment by Application
11.1 Global Rufinamide Revenue Market Share by Application (2014-2019)
11.2 Rufinamide Market Forecast by Application (2019-2024)
11.3 Adults Revenue Growth (2014-2019)
11.4 Pediatric patients Revenue Growth (2014-2019)
12 Global Rufinamide Market Size Forecast (2019-2024)
12.1 Global Rufinamide Market Size Forecast (2019-2024)
12.2 Global Rufinamide Market Forecast by Regions (2019-2024)
12.3 North America Rufinamide Revenue Market Forecast (2019-2024)
12.4 Europe Rufinamide Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Rufinamide Revenue Market Forecast (2019-2024)
12.6 South America Rufinamide Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Rufinamide Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Rufinamide Picture
Table Product Specifications of Rufinamide
Table Global Rufinamide and Revenue (Million USD) Market Split by Product Type
Figure Global Rufinamide Revenue Market Share by Types in 2018
Figure Tablets Picture
Figure Oral suspension Picture
Table Global Rufinamide Revenue (Million USD) by Application (2014-2024)
Figure Rufinamide Revenue Market Share by Applications in 2018
Figure Adults Picture
Figure Pediatric patients Picture
Table Global Market Rufinamide Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Rufinamide Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Rufinamide Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Rufinamide Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Rufinamide Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Rufinamide Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Rufinamide Revenue (Million USD) and Growth Rate (2014-2024)
Table Eisai Basic Information, Manufacturing Base and Competitors
Table Eisai Rufinamide Type and Applications
Table Eisai Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
Table Glenmark Pharms Basic Information, Manufacturing Base and Competitors
Table Glenmark Pharms Rufinamide Type and Applications
Table Glenmark Pharms Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan Basic Information, Manufacturing Base and Competitors
Table Mylan Rufinamide Type and Applications
Table Mylan Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
Table West-ward Pharms Basic Information, Manufacturing Base and Competitors
Table West-ward Pharms Rufinamide Type and Applications
Table West-ward Pharms Rufinamide Revenue, Gross Margin and Market Share (2017-2018)
Table Global Rufinamide Revenue (Million USD) by Players (2014-2019)
Table Global Rufinamide Revenue Share by Players (2014-2019)
Figure Global Rufinamide Revenue Share by Players in 2017
Figure Global Rufinamide Revenue Share by Players in 2018
Figure Global Top 5 Players Rufinamide Revenue Market Share in 2018
Figure Global Top 10 Players Rufinamide Revenue Market Share in 2018
Figure Global Rufinamide Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Rufinamide Revenue (Million USD) by Regions (2014-2019)
Table Global Rufinamide Revenue Market Share by Regions (2014-2019)
Figure Global Rufinamide Revenue Market Share by Regions (2014-2019)
Figure Global Rufinamide Revenue Market Share by Regions in 2018
Figure North America Rufinamide Revenue and Growth Rate (2014-2019)
Figure Europe Rufinamide Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Rufinamide Revenue and Growth Rate (2014-2019)
Figure South America Rufinamide Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Rufinamide Revenue and Growth Rate (2014-2019)
Table North America Rufinamide Revenue by Countries (2014-2019)
Table North America Rufinamide Revenue Market Share by Countries (2014-2019)
Figure North America Rufinamide Revenue Market Share by Countries (2014-2019)
Figure North America Rufinamide Revenue Market Share by Countries in 2018
Figure USA Rufinamide Revenue and Growth Rate (2014-2019)
Figure Canada Rufinamide Revenue and Growth Rate (2014-2019)
Figure Mexico Rufinamide Revenue and Growth Rate (2014-2019)
Table Europe Rufinamide Revenue (Million USD) by Countries (2014-2019)
Figure Europe Rufinamide Revenue Market Share by Countries (2014-2019)
Figure Europe Rufinamide Revenue Market Share by Countries in 2018
Figure Germany Rufinamide Revenue and Growth Rate (2014-2019)
Figure UK Rufinamide Revenue and Growth Rate (2014-2019)
Figure France Rufinamide Revenue and Growth Rate (2014-2019)
Figure Russia Rufinamide Revenue and Growth Rate (2014-2019)
Figure Italy Rufinamide Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Rufinamide Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Rufinamide Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Rufinamide Revenue Market Share by Countries in 2018
Figure China Rufinamide Revenue and Growth Rate (2014-2019)
Figure Japan Rufinamide Revenue and Growth Rate (2014-2019)
Figure Korea Rufinamide Revenue and Growth Rate (2014-2019)
Figure India Rufinamide Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Rufinamide Revenue and Growth Rate (2014-2019)
Table South America Rufinamide Revenue by Countries (2014-2019)
Table South America Rufinamide Revenue Market Share by Countries (2014-2019)
Figure South America Rufinamide Revenue Market Share by Countries (2014-2019)
Figure South America Rufinamide Revenue Market Share by Countries in 2018
Figure Brazil Rufinamide Revenue and Growth Rate (2014-2019)
Figure Argentina Rufinamide Revenue and Growth Rate (2014-2019)
Figure Colombia Rufinamide Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Rufinamide Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Rufinamide Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rufinamide Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Rufinamide Revenue Market Share by Countries in 2018
Figure Saudi Arabia Rufinamide Revenue and Growth Rate (2014-2019)
Figure UAE Rufinamide Revenue and Growth Rate (2014-2019)
Figure Egypt Rufinamide Revenue and Growth Rate (2014-2019)
Figure Nigeria Rufinamide Revenue and Growth Rate (2014-2019)
Figure South Africa Rufinamide Revenue and Growth Rate (2014-2019)
Table Global Rufinamide Revenue (Million USD) by Type (2014-2019)
Table Global Rufinamide Revenue Share by Type (2014-2019)
Figure Global Rufinamide Revenue Share by Type (2014-2019)
Figure Global Rufinamide Revenue Share by Type in 2019
Table Global Rufinamide Revenue Forecast by Type (2019-2024)
Figure Global Rufinamide Market Share Forecast by Type (2019-2024)
Figure Global Tablets Revenue Growth Rate (2014-2019)
Figure Global Oral suspension Revenue Growth Rate (2014-2019)
Table Global Rufinamide Revenue by Application (2014-2019)
Table Global Rufinamide Revenue Share by Application (2014-2019)
Figure Global Rufinamide Revenue Share by Application (2014-2019)
Figure Global Rufinamide Revenue Share by Application in 2019
Table Global Rufinamide Revenue Forecast by Application (2019-2024)
Figure Global Rufinamide Market Share Forecast by Application (2019-2024)
Figure Global Adults Revenue Growth Rate (2014-2019)
Figure Global Pediatric patients Revenue Growth Rate (2014-2019)
Figure Global Rufinamide Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Rufinamide Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Rufinamide Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Rufinamide Revenue Market Forecast (2019-2024)
Figure Europe Rufinamide Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Rufinamide Revenue Market Forecast (2019-2024)
Figure South America Rufinamide Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Rufinamide Revenue Market Forecast (2019-2024)
世界のエトラビリン市場予測（～2024年） Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etrav…- 世界のロミプロスチム市場予測（～2024年） Romiplostim (rINN, USAN) is a fusion protein analog of thrombopoietin, a hormone that regulates platelet production. Scope of the Report: The global Romiplostim market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 201…
- 世界のアルモダフィニル市場予測（～2024年） Armodafinil (trade name Nuvigil) is the enantiopure compound of the eugeroic modafinil (Provigil). It consists of only the (R)-(−)-enantiomer of the racemic modafinil. Scope of the Report: The global Armodafinil market is valued at xx million USD in 2018 and is expected to reach xx million USD by th…
- 世界のオロパタジン眼科市場予測（～2024年） Olopatadine eye drops (Pazeo, Patanol, Pataday) are used to treat itchy eyes caused by allergies. Scope of the Report: The global Olopatadine Ophthalmic market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 20…
- 世界の小児慢性副鼻腔炎治療市場予測（～2024年） Pediatric chronic Rhinosinusitis is one of the major and common disorder among infants with significant morbidity. Its diagnosis involves sinus symptoms, with prolonged duration requiring standard medical therapy for more than 90 days. The main causative factors for pediatric chronic rhinosinusitis …